We reach more than 65,000 registered users in Dec!!

Sci-Tech Science News Physics Videos Psychology Geology

Needing more viruses, Novartis taps Catalent to boost manufacturing of its new gene therapy Zolgensma

Like  Save

Virus shortages are forcing gene therapy firms to build their own manufacturing facilities and work with contract manufacturers at the same time

Cite This Article as
"Needing more viruses, Novartis taps Catalent to boost manufacturing of its new gene therapy Zolgensma", MachPrinciple, July 21, 2019, https://machprinciple.com/post/Needing-more-viruses-Novartis-taps-Catalent-to-boost-manufacturing-of-its-new-gene-therapy-Zolgensma

    No tags found for this post

Leave a comment

0Likes

0Comments

Like   Share Share